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http:WHAT THIS PAPER ADDS
Aortic aneurysm screening is in a transition period, in which implementation has occurred and now it is being
reﬁned. This article adds to the growing body of evidence detailing the differences between the two main
methods of aortic sizing; it also adds weight to the idea of including sub-aneurysmal aortas into the screening
programme.Introduction: The NHS Abdominal Aortic Aneurysm Screening Programme (NAAASP) uses the maximal anterior to
posterior (AP) inner-to-inner (ITI) wall diameter in sizing aortic dimensions when screening with ultrasound. It is
recognised that ITI measurements are smaller than outer-to-outer (OTO) measurements, and the primary aim
was to calculate the absolute difference in AP ITI and OTO measurements across varying aortic diameters. The
secondary aim was to estimate the potential number of patients lost from the screening programme.
Methods: Since April 2012, patients outside the screening programme that undergo ultrasound of abdominal
aortas have their ITI and OTO measurements recorded. These measurements were compared retrospectively and
analysed for variability at threshold sizes of AAAs.
Results: From May 2012 to October 2013, 452 abdominal aortic ultransound scans recorded both ITI and
OTO measurements. The majority (81%) were performed on men with the mean age of 78 years. The mean
difference between ITI and OTO measurements was 4.21 mm (p < .001). There was no difference between the
genders. Thresholds were created for analysis between different ITI and OTO aortic diameters; these were
<3 cm, 3.1e4 cm, 4.1e5 cm, and >5 cm. There was no signiﬁcant difference between the means at each
threshold size for ITI diameter (p ¼ .758). In the ﬁrst 2 years from April 2012, 15,447 men underwent screening.
Of these, 177 (1.14%) had sub-threshold ITI aortic diameters between 2.6 cm and 2.9 cm. This would upscale to
5,316 men nationally.
Conclusion:We have demonstrated a consistent and signiﬁcant 4mm difference between ITI and OTO diameters in
live scanning. Lowering the threshold for entry into a surveillance AAAs to an ITI diameter of 26 mm rather than the
current 30 mm is advocated. An alternative cost-effective way is to rescreen this small sub-group at 5 or 7 years.
 2014 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Abdominal aortic aneurysms (AAAs) predominantly occur in
1.5e3% of men aged over 65.1e3 Ultrasound (US) can
reliably visualise the aorta in 99% of individuals, allowing
detection of AAAs before rupture.4 US has also been shown
to accurately size AAAs when compared to reconstructed
three-dimensional (3D) computed tomography (CT).5 The
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trials concluded the risk of mortality from rupture of small
aneurysms (4.0e5.5 cm) was less than for operative inter-
vention or from another unrelated cause,6,7 thus allowing a
window of opportunity for detection, surveillance, and
medical optimisation. As the majority of aneurysms are
asymptomatic until rupture, it was postulated that
screening for AAAs would decrease deaths from ruptured
AAA sand be cost-effective. This was conﬁrmed by the
Multicentre Aneurysm Screening Study (MASS).8 In the pre-
abdominal aortic aneurysm screening era, ruptured AAAs
accounted for between 6,000 and 8,000 deaths each year in
the UK.2
The NHS AAA Screening Program (NAAASP) was
announced by the Department of Health in 2008. The
phased implementation began in 2009 with coverage
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was the modality of choice for screening as it is reliable,
non-invasive, and relatively inexpensive.10 Traditionally US
anterior to posterior (AP) diameter is used to size AAAs; this
was proven to be an accurate reproducible measurement
with low inter-observer variability.11,12 With time, two
techniques for measurement of the aortic wall have been
developed: inner to inner (ITI) and outer to outer (OTO)
diameter. Recently, a third measurement has been
described: leading edge to leading edge (LTL).13
The UKSAT made their recommendations based on AP
OTO measurements,6 which are accepted thresholds for
considering surgical intervention. MASS used the ITI to
assess mortality beneﬁt and cost-effectiveness.8 Despite the
treatment threshold being formulated using the OTO
measurement, NAAASP uses the ITI measurement in their
screening assessments. This was based on the MASS trial
and a more recent study, which found better repeatability
of AP ITI measurement as opposed to a greater variability in
the OTO measurements when performed by screening
technicians.14
Despite the better reproducibility of the ITI method, it
naturally gives a smaller diameter than OTO measurement.
This has been shown to be as high as 6 mm, which would
have an inﬂuence on those who are screened.15 A more
recent paper shows a 4-mm difference between the OTO
and ITI measurements in a small sample of static images.16
NAAASP recommend inclusion into a surveillance pro-
gramme for AAAs that measure 30 mm or over in AP ITI
diameter. AAAs that are 55 mm or greater are referred for
surgical intervention.6,17,18
It is postulated that using the AP ITI measurement results
in patients with small sub-threshold aortic diameters being
excluded from the screening programme. Besides the falling
rates for incidence of AAAs,19 this could also account for the
lower detection rates seen in NAAASP than MASS. This may
also affect those with larger AAAs over 55 mm, potentially
downscaling them and delaying surgical intervention.
To coincide with the implementation of the Staffordshire
& South Cheshire AAA Screening Programme in April 2012,
the vascular sonographers and radiologists at the Vascular
Hub Centre were asked to provide AP ITI and OTO mea-
surements on all patients attending the University Teaching
Hospital for abdominal aortic scans. The primary aim of this
retrospective study was to establish the absolute difference
between AP ITI and OTO measurements. Since it is recog-
nised that the ITI measurements are generally smaller than
OTO measurements, the secondary aim was to estimate the
potential number of patients lost from the screening
programme.METHODS
In preparation for the local screening programme, the
Vascular Laboratory at the University Teaching Hospital
Vascular Hub centre were asked to provide the AP ITI and
OTO US measurements on patients where AAAs were sus-
pected, or on patients with a known AAA entered into thelocal hospital-based surveillance programme. These were
live measurements. Data were collected between May 2012
and October 2013. Seven qualiﬁed vascular sonographers or
radiologists performed all scans via the trans-abdominal
technique. Scans were performed using a Philips IU22
scanner with a C5-1 transducer. Formal radiology reports
were used to retrospectively gather the AP ITI and OTO
diameters. Only one measurement was provided for non-
aneurysmal aortas measuring 25 mm or less.
Measurement technique
A normal aorta is measured in the AP projection in the
sagittal plane (LS) OTO during systolic expansion as this
gives the most accurate and reproducible measurement.
Measuring the aorta in the transverse plane (TS) leads to
errors if the vessel is tortuous/ectatic and the vessel walls
lie parallel to the ultrasound beam giving poor edge detail.
For AAAs, NAAASP requests that the AP diameter of the
aorta is measured in both the LS and the TS planes at peak
systole, placing the horizontal component of the calliper on
the inner most aspect of the aortic wall anteriorly and
posteriorly. However, it is important that the inner wall
calliper is not placed on the inner border of any mural
thrombus.
Similarly, to perform an OTO measurement the horizontal
component of the calliper is placed on the outermost sur-
face of the aortic wall anteriorly and posteriorly.
Aortic measurements were performed live in real time
using the calliper software installed with the Philips IU22
scanner and recorded in the ofﬁcial report.
Sonographer training
The vascular sonographers have received training through a
NAAASP-approved training centre in Salford. All participated
in validation of the local screening programme, and the
senior sonographer is a NAAASP trainer.
NAAASP data
NAAASP provided 2-year AAA screening data for the Staf-
fordshire & South Cheshire Programme for the period April
11, 2012, to the March 31, 2014.
Statistical analysis
Data were entered onto a database and the ITI and OTO
variables were compared using the paired sample t test and
the independent samples t test. Comparison of intravariable
means was performed by analysis of variance (ANOVA). A
p-value <.05 was considered statistically signiﬁcant. All
statistical analyses were performed with SPSS statistical
software version 20 (SPSS, Inc., Chicago IL).
RESULTS
From May 2012 to October 2013, of the 822 abdominal
aortic scans coded, 806 aortic scans were performed. Of
these, 452 had both AP ITI and OTO measurements recor-
ded. The majority, 364 (80%), of the scans were performed
Table 2. Mean difference in aortic diameter; thresholds based on
outer to outer wall aortic diameter.
Group Number Mean (mm) 95% Conﬁdence
interval (mm)
1 (<30 mm) 14 3.36 2.46e4.25
2 (31e40 mm) 94 3.85 3.58e4.12
3 (41e50 mm) 200 4.28 4.07e4.48
4 (>50 mm) 144 4.44 4.13e4.76
30 L. Meecham et al.on men. The mean age was 78 years. The mean difference in
ITI and OTO measurements was 4.21 mm (range 1e16 mm,
p < .001). The mean difference based on gender was
4.29 mm for men and 3.85 mm for women; this was not
statistically signiﬁcant (p ¼ .348).
Furthermore differences in mean ITI and OTO diameters
were compared for deﬁned groups based on increasing
aortic sizes. Thresholds were grouped as <30 mm (Group
1), 31e40 mm (Group 2), 41e50 mm (Group 3), and
>50 mm (Group 4). The ITI measurements demonstrated no
signiﬁcant difference between the means (p ¼ .758) when
compared for the threshold groups (Table 1). However, the
mean OTO diameters increased as aortic size increases, with
the differences in means across the threshold groups
reaching statistical signiﬁcance (p ¼ .007) (Table 2).
Over the ﬁrst 2 years from March 29, 2012, to the April
10, 2014, 15,477 subjects were scanned in the Staffordshire
& South Cheshire AAA Screening Programme. Of these, 199
(1.29%) were found to have small aneurysms requiring
surveillance, 26 (0.17%) were found to have larger aneu-
rysms that required treatment, and 177 (1.14%) had a
maximal AP ITI aortic diameters of 26e29 mm. The last sub-
set of patients have not been offered further follow-up as
per NAAASP protocol.
Nationally, 204,945 subjects were scanned in 2012e
2013, and 261,342 for the year 2013e2014.17 Extrapolating
the results to the national programme, 1.14% would equate
to approximately 5,316 patients for the 2-year period
2012e14.
DISCUSSION
Although a difference between the AP ITI and OTO mea-
surements was inevitable, the main questions were what is
the absolute difference, is it signiﬁcant, and if so, is it
responsible for excluding subjects from the beneﬁts of AAA
screening? It was found that in a practical sense this would
be consistent at 4 mm, which is reproducible between
operators.
Consistency was also observed when examining the mean
aortic ITI diameters across varying aortic sizes, with lack of
inter-observer variation suggesting reproducibility. These
ﬁndings support the study by Hartshorne and colleagues,14
which demonstrated the reproducibility of the ITI mea-
surements when compared with OTO. This study did have
some limitations: all measurements were performed on
static images and not in real-life conditions. Consequently,
there is much less information with regard to the repro-
ducibility of both measurements in live scanning.Table 1. Mean difference in aortic diameter; thresholds based on
inner to inner wall aortic diameter.
Group Number Mean (mm) 95% Conﬁdence
interval (mm)
1 (<30 mm) 38 4.18 3.63e4.73
2 (31e40 mm) 154 4.31 4.04e4.59
3 (41e50 mm) 197 4.19 3.99e4.39
4 (>50 mm) 63 4.06 3.61e4.52Why is this study different? All previously published work
comparing the difference between ITI and OTO had been
performed on static images on a remote computer; there
was no patient interaction. In the study the measurements
were performed live while the patient was attending the
scan. The results therefore are gathered in the same
manner as those that would be recorded in the screening
programme. This study mimics real-life conditions, and
therefore the results can reliably be applied in every-day
clinical application.
From its inception in April 2012 over a two year period,
the detection rate for the Staffordshire & South Cheshire
AAA Screening Programme is 1.46% and for the overall
National NHS AAA Screening Programme currently 1.4%
(18). This is lower than reported in a Swedish study from
2011,19 where the detection rate was 1.7% with a preva-
lence rate of 2.2%. Both the UK and the Swedish studies
report lower AAA incidence rates than the 4.9% from the
original MASS.8 If those subjects with sub-threshold aortas
measuring between 2.6 and 2.9 cm in ITI diameter (1.14%)
were included, the detection rate would increase to 2.6%.
This may explain the discrepancy in detection rates be-
tween MASS and NAAASP, and would be more in keeping
with expected detection rates, recognising that there has
been a mean reduction in aortic diameter over the years as
reported by Darwood and colleagues in 2012.20
The authors are not advocating an alteration of scanning
technique for NAAASP; this would be impractical, would
require retraining of all screening technicians and revali-
dation. The reproducibility in the measurements of the ITI
diameters supports the method currently in use by NAAASP.
Instead, lowering the threshold of inclusion to a programme
of surveillance from an AP ITI diameter of 30 mm to on of
26 mm is proposed. This would capture all of the truly
aneurysmal aortas and is supported by the Gloucestershire
AAA screening 20-year review that included aortas over
26 mm20; MASS only included aortas that measured over
30 mm ITI diameters.8
Does size matter? Clearly it does, as recent publications of
long-term follow-up studies have observed increased
rupture rates in previously normal scanned subjects.21e24
The 10-year results of MASS questioned the need for
further follow-up scanning, as rates of rupture beginning to
increase from years 8, 9, and 10 were cited. It was
hypothesised that this may be due to patients with sub-
aneurysmal dilatation becoming aneurysmal during the
follow-up period. Sustained cost-effectiveness of a screening
programme using ITI measurements after 10 years was also
reported, despite spiralling health-care costs.21
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study22 showed that sub-aneurysmal dilatation of the aorta
of 26e30 mm progressed to become aneurysmal. At 5 years
after the initial scan, this was found to be 59%, and at 10
years it was 96%. Six centres contributed to this study with
a mixture of ITI and OTO measurements. It was also found
that rates of progression from dilated aorta to aneurysmal
aorta (30 mm) were not statistically signiﬁcant between the
two groups (4.6 years vs. 4.7 years). This was also the case
for reaching the treatment threshold (55 mm) on ITI versus
OTO measurement, which was 12.9 versus 14.7 years
respectively. Although it was concluded that this was not
statistically signiﬁcant, OTO measurements consistently
took longer to progress to the treatment threshold.
Hafez et al.25 agreed with Wild et al.’s22 ﬁndings and
concluded that 0.9% subjects with sub-aneurysmal dilata-
tion of the aorta progressed to the treatment threshold in
5 years; this increased to 20% by 10 years. These data
suggest it is safe to wait up to 5 years before repeat US scan
of this speciﬁc subgroup.
Other studies have examined the increasing risk of late
rupture. The 15-year follow-up of the UK Chichester trial
suggested an increase in ruptured AAAs during later follow-
up.23 The 14-year follow-up of the Danish Viborg trial un-
fortunately did not report on ruptured AAAs among those
that screened normal.10
The 13-year follow-up of MASS analysed rupture rates in
those who had a normal aortic screening on US. It was
found that 59 ruptured AAAs occurred after a normal ﬁrst
scan. Of these, 32 baseline scans were available and 18 had
aortic diameters between 25 and 29 mm. Although rupture
risk reduction remained around 50%, the authors felt this
was beginning to erode the long-term beneﬁt from the AAA
screening programme.26 A comment on this study sug-
gested repeat scanning at 6e7 years for normal individuals
and inclusion of those measuring between 25e29 mm in
yearly surveillance.24
The authors are not advocating entering this sub-group of
patients into yearly surveillance. There is no consensus
about what interval would be acceptable. The RESCAN
collaborators estimated an average of 7.4 years for a 3-cm
aneurysm to expand to the treatment threshold.27 A sur-
veillance scan at 5 or indeed 7 years would seem to be an
acceptable and sensible compromise. This would also in-
crease the cost-effectiveness of the surveillance programme
in this small sub-group of patients while continuing to
maintain standards of safety for patients.
Currently the only European countries to have fully
established national screening for AAAs are the UK and
Sweden. Others, such as Norway and Denmark, are investi-
gating the feasibility in their respective health systems. The
question over which measurement method to employ will
eventually have to be considered.The data allow comparison
between the two main methods, giving a 4-mm constant for
comparison.This in effect allows anymethod to be employed
and the inclusion criteria to be adjusted as appropriate.
This study is not without its limitations. Unfortunately a
proportion of scans performed did not have ITI and OTOmeasurements documented for analysis. This could have
been overcome by requesting ultrasonographers re-report
their static images. This was not appropriate as the au-
thors did have a large number of scans with both mea-
surements recorded and the expectation that
measurements should be recorded on live images. Statisti-
cally this has not hindered the results. Also, this study is
retrospective; a prospective collection with duplication of
measurements performed by different sonographers would
add greater reliability, reproducibility, and evidence to
support the ﬁndings. It would also be useful to answer the
question whether the 4-mm difference between ITI and
OTO measurements are applicable to the truly sub-
aneurysmal or normal aortas measuring less than 25 mm.
The authors did not have the potential to investigate this in
the study and this would be an interesting question for
further research.
CONCLUSION
In live scanning, a consistent and signiﬁcant difference of
just over 4 mm between OTO and ITI diameters across
varying AAA sizes has been demonstrated. The 177 sub-
threshold men in this programme would upscale to 5,316
men in NAASP for the 2-year period 2012e2014.
Lowering the threshold for entry into a surveillance
programme screening for AAAs, to an ITI diameter of 26 mm
rather than the current 30 mm is advocated. An alternative
cost-effective way is to re-screen this small subgroup of
approximately 1% of patients at longer intervals, perhaps at
5 or 7 years. The inclusion of smaller sizes requires further
investigation by large-scale studies, possibly by NAAASP
itself.
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